Brown Cancer Center. Making tomorrow BRIGHTER for everyone.

 

Breast Cancer: Clinical Trials

Clinical Trials and Research

  • 07.0072  - A Randomized Phase III Trial of Neoadjuvant Therapy in Patients with Palpable and Operable Breast Cancer Evaluating the Effect on Pathologic Complete Response (pCR) of Adding Capecitabine or Gemcitabine to Docetaxel when Administered Before AC with or without Bevacizumab and Correlative Science Studies Attempting to Identify Predictors of High Likelihood for pCR with Each of the Regimens learn more
  • 05.0511 - Suppression of Ovarian Function Trial (SOFT) - A Phase III Trial Evaluating the Role of Ovarian Function Suppression and the Role of Exemestane Adjuvant Therapies for Premenopausal Women with Endocrine Responsive Breast Cancer Tamoxifen versus Ovarian Function Suppression + Tamoxifen Versus Ovarian Function Suppression + Exemestane learn more
  • 06.0362 - Program for the Assessment of Clinical Cancer Tests (PACCT-1): Trial Assigning Individualized Options for Treatment the TAILORx Trial learn more

home | contact | about | send to a friend